Cheng Wen1, Xingming Li2, Lihui Huang3, Xianlei Wang1, Xuelei Zhao1, Xiaohua Cheng1, Wenying Nie4, Xiangrong Tang5, Fang Ge6, Dinghua He7, Shujun Hu8, Jin Zheng8, Di Zhang9, Chunxiu Wen10, Jin Zhang11, Chuan Wang12, Lixia Ma13, Ying Lin14, Yaqiu Chen15, Man Gao16, Junning Han17. 1. Beijing Tongren Hospital, Capital Medical University, Beijing, 100005, China; Beijing Institute of Otolaryngology, Beijing, China; Key Laboratory of Otolaryngology, Head and Neck Surgery, Ministry of Education, Beijing, China. 2. Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, 100069, China. 3. Beijing Tongren Hospital, Capital Medical University, Beijing, 100005, China; Beijing Institute of Otolaryngology, Beijing, China; Key Laboratory of Otolaryngology, Head and Neck Surgery, Ministry of Education, Beijing, China. Electronic address: huangpub@126.com. 4. Jinan Maternal and Child Health Care Center, Jinan, Shandong Province, 250001, China. 5. Liuzhou Maternal and Child Health Care Center, Liuzhou, Guangxi Province, 545001, China. 6. Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang, Hebei Province, 050000, China. 7. Hunan Maternal and Child Health Care Center, Changsha, Hunan Province, 410000, China. 8. Maternal and Child Health Care Center of Luoyang, Luoyang, Henan Province, 471000, China. 9. Langfang Maternal and Child Health Center, Langfang, Hebei Province, 065000, China. 10. Maternal and Child Health Care Center of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Province, 530000, China. 11. Department of Otolaryngology, The People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, 830001, China. 12. Beijing Chaoyang Maternal and Child Health Care Hospital, Beijing, 100021, China. 13. Beijing Maternity Hospital, Beijing, 100026, China. 14. Department of Otolaryngology Head and Neck Surgery, First Affliated Hospital(Xijing Hospital), Military Medical University of Air Force, Xi'an, Shanxi Province, 710032, China. 15. Tianjin Maternal and Child Health Care Center, Tianjin, 300070, China. 16. Hearing Impairment Diagnosis Center, Dezhou Maternal and Child Health Care Hospital, Dezhou, Shandong Province, 253000, China. 17. Zibo Maternal and Child Health Hospital, Zibo, Shandong Province, 255000, China.
Abstract
OBJECTIVES: The present study aimed to determine the status of a universal newborn hearing screening (UNHS) program being conducted in parts of China, by comparing differences in the program findings between 2016 and 2017, as well as across regions in China. METHODS: This study investigated a nationally representative sample of newborns from 26 provinces, autonomous regions, and municipalities in mainland China. A ''Newborn Hearing Screening Survey'' questionnaire was sent to 43 hearing screening institutions throughout China and the data were analyzed, with appropriate quality control throughout the study process. RESULTS: Twenty-six questionnaires, covering 55.88% (19/34) of the provincial administrative regions in China were appropriately completed. The overall sampling frame comprised 238,795 (year 2016) and 229,185 (year 2017) newborns, respectively. We found differences between two years, the initial screening coverage in 2017 (96.10%) was higher than that in 2016 (94.96%); the referral rate at initial screening in 2017 (9.21%) was lower than that in 2016 (10.26%); and the rescreening rate in 2017 (73.50%) was higher than that in 2016 (68.44%). We found differences across three regions, the rescreening rate were highest in West China, the referral rate at rescreening and the referral rate to diagnostic audiological assessment diagnosis were both highest, while the hearing-loss rate was lowest, in the East China in two years. Overall, 61.54% (n = 16) reported using otoacoustic emissions (OAEs), while 38.46% (n = 10) reported using OAEs in combination with automated auditory brainstem response (AABR) tests, for the initial screening. For rescreening, most sites (n = 19, 73.08%) reported using OAEs in combination with AABR, followed by OAEs only (n = 4, 15.38%) and AABR only (n = 3, 11.54%). Of the twenty-six institutions, 57.69% (n = 15) were equipped with a digital information management system for UNHS program, East China had the highest rate of it (81.82%, 9/11). CONCLUSIONS: This study indicated that implementation of a UNHS program had essentially been achieved in many regions of China under the guidance of technical specifications for newborn hearing screening. Compared with 2016, the overall quality of the UNHS program had improved in 2017 and that in East China was better than in the Midland and West China. However, national quality control of the UNHS program is still required to enhance the quality of the program and public education needs to be emphasized to improve the rescreening and reception rate.
OBJECTIVES: The present study aimed to determine the status of a universal newborn hearing screening (UNHS) program being conducted in parts of China, by comparing differences in the program findings between 2016 and 2017, as well as across regions in China. METHODS: This study investigated a nationally representative sample of newborns from 26 provinces, autonomous regions, and municipalities in mainland China. A ''Newborn Hearing Screening Survey'' questionnaire was sent to 43 hearing screening institutions throughout China and the data were analyzed, with appropriate quality control throughout the study process. RESULTS: Twenty-six questionnaires, covering 55.88% (19/34) of the provincial administrative regions in China were appropriately completed. The overall sampling frame comprised 238,795 (year 2016) and 229,185 (year 2017) newborns, respectively. We found differences between two years, the initial screening coverage in 2017 (96.10%) was higher than that in 2016 (94.96%); the referral rate at initial screening in 2017 (9.21%) was lower than that in 2016 (10.26%); and the rescreening rate in 2017 (73.50%) was higher than that in 2016 (68.44%). We found differences across three regions, the rescreening rate were highest in West China, the referral rate at rescreening and the referral rate to diagnostic audiological assessment diagnosis were both highest, while the hearing-loss rate was lowest, in the East China in two years. Overall, 61.54% (n = 16) reported using otoacoustic emissions (OAEs), while 38.46% (n = 10) reported using OAEs in combination with automated auditory brainstem response (AABR) tests, for the initial screening. For rescreening, most sites (n = 19, 73.08%) reported using OAEs in combination with AABR, followed by OAEs only (n = 4, 15.38%) and AABR only (n = 3, 11.54%). Of the twenty-six institutions, 57.69% (n = 15) were equipped with a digital information management system for UNHS program, East China had the highest rate of it (81.82%, 9/11). CONCLUSIONS: This study indicated that implementation of a UNHS program had essentially been achieved in many regions of China under the guidance of technical specifications for newborn hearing screening. Compared with 2016, the overall quality of the UNHS program had improved in 2017 and that in East China was better than in the Midland and West China. However, national quality control of the UNHS program is still required to enhance the quality of the program and public education needs to be emphasized to improve the rescreening and reception rate.